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maging for Coronary Risk Assessment:
eady for Prime Time?
I N C E T H E I N T R O D U C T I O N O F T H E C O N C E P T O F C A R D I O V A S C U L A R
I S K F A C T O R S in 1961 by the Framingham Heart Study investigators (1), clinicians and patients
ave been seeking better tools to assess the likelihood of future cardiovascular events. As our knowledge
n this area has grown, so has the clinician’s armamentarium, from a simple history and physical examina-
ion to laboratory testing and biomarkers and, most recently, to imaging of atherosclerotic plaque.
owever, the gold standard still remains the Framingham Risk Score (FRS), which ignores the strong
orrelations between abnormalities detected by these alternative methods and both incident and preva-ent coronary artery disease (CAD).
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tor carotid intima media thickness, the
RIC (Atherosclerosis Risk In Communi-
ies) study first demonstrated such correla-
ions in the 1990s (2), and recent preliminary
ata from the MESA (Multi-Ethnic Study of
therosclerosis) regarding the predictive
ower of coronary artery calcification (CAC)
3) has again demonstrated a relationship be-
ween imaging results and outcomes while
xtending its validity across all ethnicities and
oth genders. Perhaps the ultimate noninva-
ive imaging tool for coronary disease, coro-
ary artery computed tomography angiogra-
hy (CTA), has had a recent boost with the
resentation of the CORE 64 multisite re-
ults indicating the high accuracy of 64-slice
T in comparison with invasive coronary
ngiography (4).
However, although many risk scores are
pidemiologically associated with prognosis,
redictive power for events in individual pa-
ients is limited. Further, no risk assessment
trategy—not FRS, not biomarkers (such as
igh-sensitivity C-reactive protein), not im-
ging—has ever been proven in a randomized
rial to reduce cardiovascular events. The
tudies simply have not been done and, given
he financial and logistic hurdles, are unlikely
ver to be done. For some observers, this lack pf evidence is a critical flaw, and precludes
ncorporation of imaging into routine care al-
orithms (5). For others, it is a minor detail,
endered even more insignificant given the
nlikelihood of a randomized trial and by
mprovements in preventive therapies and risk
ssessment tools. For these individuals, it may
e a case of precision versus pragmatism.
What is the future for atherosclerosis risk
ssessment by imaging? Must we perform
andomized controlled trials of an imaging
AD risk assessment strategy using clinical
ndpoints to determine if imaging risk assess-
ent really can save lives? Or do we have
nough information already to recommend
outine imaging in selected groups of asymp-
omatic individuals?
We have invited 2 experts to comment on
he new imaging data supporting the rela-
ionships between imaging and outcomes and
hether these will change how they perform
isk stratification in their clinical practices.
hat do they have to say? Would you share
our opinion with us? We encourage you to
isit iJACC-iNEWS in Cardiosource and tell
s what you think, using its “Talk-Back” fea-
ure. The opinions presented below are en-
irely of the authors and do not reflect or ex-
ress the position of the American College of
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264ardiology, JACC: Cardiovascular Im-
ging, or the editors.
Pamela S. Douglas, MD, MACC
Duke University
e Need More Evidence!
ita F. Redberg, MD, MSc, FACC
niversity of California at San Francisco
E W T E C H N O L O G Y H O L D S
R E A T P R O M I S E in our abil-
ty to obtain noninvasive images of
he coronary arteries. However, to
ustify its incorporation into clinical
ractice, cardiac imaging must go be-
ond pretty pictures to provide incre-
ental and actionable data over cur-
ent cardiac risk prediction. The
ardiac risk factors described almost
alf a century ago by the Framingham
nvestigators (1) are still accurate to-
ay; the FRS has proven to be invalu-
ble in predicting and helping to pre-
ent heart disease. Our focus for
reventing heart disease should re-
ain reducing these risk factors. In-
eed, most of the reduction in coro-
ary heart disease mortality in the last
decades is due to reduction of the
ardiac risk factors that comprise the
RS. In particular, as shown recently,
t least 44% of the decreased CAD
ortality rate in the last 2 decades
ikely is attributable to favorable
hanges in risk factors—total choles-
erol (24%), blood pressure (20%),
moking (12%), and physical inactivity
5%) (6). In contrast, there are no
ata to show that cardiac CTA is as-
ociated with any reduction in coro-
ary heart disease mortality.
Although numerous studies have
hown a high diagnostic accuracy for
ultislice cardiac CTA when com-
omputed tomography imaging data haared with invasive coronary angiog-
aphy, these data have been obtained
n highly selected populations, techni-
ally difficult cases were excluded, and
xperienced physicians interpreted the
mages in high-volume centers. Simi-
ar diagnostic accuracy would be un-
ikely in routine use. More impor-
antly, there are no studies showing
ffect of CT on prognosis or on clini-
al events. In the only randomized
ontrol trial to examine this issue, re-
earchers found that using coronary
alcification screening to motivate pa-
ients to make evidence-based changes
n risk factors was not associated with
mprovement in modifiable cardiovas-
ular risk at 1 year (7). Despite this
ack of outcomes data, there has been
call for more “imaging for preven-
ion” by the American Society of Nu-
lear Cardiology (8). There are serious
isks to this approach. Recent data
uggest that the increase in CT imag-
ng from 3 million scans in 1980 to
2 million scans in 2005 may lead to
s many as 3 million additional cancer
ases in the next few decades (9).
The value of this new technology is
n unanswered question. For imaging
o be used for prevention, the objec-
ive must be more than simply beauti-
ul pictures (10). The images must be
hown to offer useful prognostic in-
ormation incremental to the FRS.
omputed tomography imaging data
ave no real value unless they lead to
ctions that improve outcomes over
ctions that already would be taken
ased on risk factors. Before we em-
race the new imaging technology, we
hould insist on evidence that it will
mprove patient outcomes. In the ab-
ence of such evidence, to further the
oal of prevention, we should con-
no real value unless they lead to actions
winue to emphasize the measures we
now for certain will reduce CAD
nd save lives, such as stanching the
besity epidemic (and its accompany-
ng increase in diabetes), by increasing
hysical activity and heart-healthy
iet adherence, reducing hypertension
nd hypercholesterolemia, and elimi-
ating smoking.
alcium Scores Refine
isk Prediction. . .
oger S. Blumenthal, MD, FACC,
nd Marietta Ambrose, MD
he Johns Hopkins Ciccarone Center for
revention of Heart Disease
N A C C U R A T E D E T E R M I -
A T I O N of cardiovascular disease
isk in an asymptomatic adult can be
ery challenging. The conventional
tratification by the FRS into the cat-
gories of low, intermediate, and high
isk is based on estimation of the 10
ear absolute risk of manifesting
AD. (11) This estimate is domi-
ated by chronologic age and not true
iologic age.
Risk stratification is fundamental in
ictating the intensity of medical
reatment. However, ambiguity lies in
ssessment of those assigned to the
ntermediate category (10% to 20%
A risk during the next decade). The
referred situation would involve re-
ning such a person’s risk to either a
ery low (6% risk) or a high risk
20%), where management guide-
ines and the evidence for them are
learer. Relevant details which may
otentially help include a family his-
ory of premature CAD and compo-
ents of the metabolic syndrome and
ther lifestyle factors not included in
he FRS.
Coronary artery calcification scores
an refine risk prediction in persons
ith an intermediate risk FRS. Theve
hat improve outcomes over actions that already would be taken based on risk factors.
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265007 American College of Cardiol-
gy/American Heart Association ex-
ert consensus document and the
006 American Heart Association
tatement on cardiac CT outline the
vidence supporting CAC scoring as
roviding significant incremental prog-
ostic information on top of the FRS
11,12). However, some individuals
ith a high burden of subclinical ath-
rosclerosis are sometimes inappropri-
tely assigned to the “low-risk” cate-
ory (10% CAD risk), which often
ccurs in women 70 years and
iddle-aged men, who will often
ave an FRS 10% despite multiple
isk factors (13).
The determination of CAC also
ay prove to be helpful in the treat-
ent of selected persons who are
lassified as low risk by their FRS.
he MESA investigators examined
ondiabetic women (mean age of 60
 9 years) who were classified as lowisk by the FRS and found that any fi
December 12, 2007.
1
1AC as compared with no CAC was
trongly predictive of CAD events (6-
old increased risk) in fully adjusted
odels (4). Moreover, advanced coro-
ary calcification (CAC score 300)
as highly predictive of future CAD
vents and also identified a group of
low-risk” women who had an 8.6%
bsolute CAD risk during a 3.75 year
eriod (14)!
Previous studies demonstrate differ-
ng prevalences in CAC by ethnicity.
eference tables and graphics describ-
ng CAC distribution by ethnicity are
ow available from the MESA study.
ecently, Nasir et al. (15) found
AC scores to be predictive of all-
ause mortality in all ethnic groups,
ith a greater CAC score portending
 worse outcome.
Accurate risk assessment and classi-
. .calcium scoring is a very reasonable ocation has important ramifications p
scoring by computed tomography in global
cardiovascular risk assessment and in evalua-
1
1
1
1or management and treatment of pa-
ients. Reassignment from an equivo-
al “intermediate risk” to “high risk”
ualifies an individual for more ag-
ressive treatment with antiplatelet
herapy, more rigorous lipid manage-
ent, and even stricter blood pressure
oals equivalent to those for persons
ith documented CAD. If the clini-
ian is not certain that a particular
atient with average or borderline risk
actor levels needs to be on life-long
spirin and aggressive lipid-lowering
herapy, coronary calcium scoring is a
ery reasonable option to refine risk
ssessment and help make that deci-
ion. Needless to add that the devel-
pment of strategies for better charac-
erization of atherosclerotic plaques,
eyond calcium scoring, would sub-
tantially refine our quest for risk
on to refine risk assessment. . .rediction.E F E R E N C E S
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